Jefferies Group LLC Avadel Pharmaceuticals PLC Put Options Transaction History

Jefferies Group LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 16, 2022	SELL	$5.46 - $8.29 $92,274 - $140,101	-16,900 Closed	0 $0
Q4 2021 Sep 21, 2023	BUY	$7.34 - $11.18 $116,706 - $177,762	15,900 Added 1590.0%	16,900 $136,000
Q4 2021 Feb 14, 2022	BUY	$7.34 - $11.18 $116,706 - $177,762	15,900 Added 1590.0%	16,900 $137,000
Q2 2021 Sep 21, 2023	BUY	$6.73 - $9.05 $6,730 - $9,050	1,000 New	1,000 $6,000
Q2 2021 Aug 20, 2021	SELL	$6.73 - $9.05 $666,270 - $895,950	-99,000 Reduced 99.0%	1,000 $7,000
Q2 2021 Aug 16, 2021	BUY	$6.73 - $9.05 $673,000 - $905,000	100,000 New	100,000 $7,000

1.07M

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $650M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.